News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,981 Results
Type
Article (20244)
Company Profile (185)
Press Release (246549)
Multimedia
Podcasts (51)
Webinars (7)
Section
Business (69392)
Career Advice (265)
Deals (10434)
Drug Delivery (64)
Drug Development (35917)
Employer Resources (37)
FDA (7853)
Job Trends (6758)
News (124377)
Policy (12260)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (1686)
Academic (1)
Accelerated approval (18)
Adcomms (14)
Allergies (77)
Alliances (20296)
ALS (87)
Alzheimer's disease (825)
Antibody-drug conjugate (ADC) (174)
Approvals (8173)
Artificial intelligence (354)
Autoimmune disease (98)
Automation (25)
Bankruptcy (67)
Best Places to Work (6419)
BIOSECURE Act (7)
Biosimilars (134)
Biotechnology (135)
Bladder cancer (98)
Brain cancer (29)
Breast cancer (407)
Cancer (2976)
Cardiovascular disease (278)
Career advice (241)
Career pathing (8)
CAR-T (169)
CDC (16)
Celiac Disease (1)
Cell therapy (467)
Cervical cancer (16)
Clinical research (32001)
Collaboration (1161)
Company closure (1)
Compensation (455)
Complete response letters (21)
COVID-19 (1213)
CRISPR (81)
C-suite (507)
Cystic fibrosis (96)
Data (4038)
Decentralized trials (1)
Denatured (23)
Depression (79)
Diabetes (303)
Diagnostics (2981)
Digital health (27)
Diversity (8)
Diversity, equity & inclusion (14)
Drug discovery (167)
Drug pricing (119)
Drug shortages (20)
Duchenne muscular dystrophy (144)
Earnings (23578)
Editorial (23)
Employer branding (2)
Employer resources (38)
Events (40727)
Executive appointments (539)
FDA (9820)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (12)
Funding (792)
Gene editing (169)
Generative AI (32)
Gene therapy (394)
GLP-1 (576)
Government (1799)
Grass and pollen (2)
Guidances (201)
Healthcare (8770)
HIV (41)
Huntington's disease (27)
IgA nephropathy (56)
Immunology and inflammation (115)
Immuno-oncology (33)
Indications (77)
Infectious disease (1350)
Inflammatory bowel disease (131)
Inflation Reduction Act (7)
Influenza (58)
Intellectual property (111)
Interviews (25)
IPO (5042)
IRA (27)
Job creations (786)
Job search strategy (211)
JPM (35)
Kidney cancer (10)
Labor market (18)
Layoffs (157)
Leadership (10)
Legal (1936)
Liver cancer (47)
Longevity (8)
Lung cancer (391)
Lymphoma (249)
Machine learning (31)
Management (13)
Manufacturing (454)
MASH (102)
Medical device (4197)
Medtech (4215)
Mergers & acquisitions (5925)
Metabolic disorders (754)
Multiple sclerosis (87)
NASH (12)
Neurodegenerative disease (178)
Neuropsychiatric disorders (43)
Neuroscience (1530)
NextGen: Class of 2026 (2412)
Non-profit (1828)
Now hiring (16)
Obesity (350)
Opinion (108)
Ovarian cancer (94)
Pain (126)
Pancreatic cancer (116)
Parkinson's disease (162)
Partnered (18)
Patents (207)
Patient recruitment (276)
Peanut (29)
People (25068)
Pharmaceutical (34)
Pharmacy benefit managers (15)
Phase 1 (9262)
Phase 2 (12996)
Phase 3 (12206)
Pipeline (3089)
Policy (152)
Postmarket research (1458)
Preclinical (3732)
Press Release (27)
Prostate cancer (151)
Psychedelics (15)
Radiopharmaceuticals (202)
Rare diseases (517)
Real estate (1773)
Recruiting (12)
Regulatory (11137)
Reports (19)
Research institute (1500)
Resumes & cover letters (28)
Rett syndrome (24)
RNA editing (11)
RSV (32)
Schizophrenia (83)
Series A (149)
Series B (124)
Sickle cell disease (77)
Special edition (10)
Spinal muscular atrophy (92)
Sponsored (22)
Startups (1537)
State (1)
Stomach cancer (8)
Supply chain (56)
Tariffs (52)
The Weekly (27)
Vaccines (429)
Venture capital (44)
Weight loss (227)
Women's health (47)
Worklife (1)
Date
Today (5)
Last 7 days (315)
Last 30 days (1273)
Last 365 days (16654)
2026 (1627)
2025 (16818)
2024 (18136)
2023 (19373)
2022 (24055)
2021 (24844)
2020 (22460)
2019 (19259)
2018 (14437)
2017 (13517)
2016 (12477)
2015 (13666)
2014 (9571)
2013 (7954)
2012 (8051)
2011 (7954)
2010 (6487)
Location
Africa (274)
Alabama (49)
Alaska (1)
Arizona (70)
Arkansas (6)
Asia (17502)
Australia (2415)
California (6117)
Canada (1428)
China (671)
Colorado (225)
Connecticut (296)
Delaware (251)
Europe (39830)
Florida (808)
Georgia (152)
Hawaii (3)
Idaho (25)
Illinois (465)
India (38)
Indiana (379)
Iowa (7)
Japan (334)
Kansas (86)
Kentucky (10)
Louisiana (16)
Maine (29)
Maryland (574)
Massachusetts (4836)
Michigan (73)
Minnesota (170)
Mississippi (1)
Missouri (98)
Montana (10)
Nebraska (8)
Nevada (35)
New Hampshire (36)
New Jersey (1880)
New Mexico (14)
New York (1531)
North Carolina (788)
North Dakota (6)
Northern California (3087)
Ohio (148)
Oklahoma (6)
Oregon (26)
Pennsylvania (1101)
Puerto Rico (6)
Rhode Island (20)
South America (330)
South Carolina (49)
Southern California (2317)
Tennessee (77)
Texas (804)
United States (21320)
Utah (173)
Vermont (1)
Virginia (145)
Washington D.C. (45)
Washington State (456)
West Virginia (1)
Wisconsin (67)
266,981 Results for "ariel precision medicine".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Precision for Medicine Broadens Global Footprint with Singapore Office Opening
February 5, 2026
·
3 min read
Press Releases
Praxis Precision Medicines, Inc. Announces Proposed Public Offering
January 7, 2026
·
4 min read
Press Releases
Praxis Precision Medicines, Inc. Announces Pricing of $575 Million Public Offering
January 7, 2026
·
4 min read
Press Releases
Praxis Precision Medicines Appoints Global Epilepsy Leader Dr. Orrin Devinsky as Head of Clinical Strategy
January 14, 2026
·
5 min read
Press Releases
Helix Announces Multi-Year Strategic Collaboration with GSK to Drive Precision Medicine Development
January 8, 2026
·
1 min read
Press Releases
Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments
January 9, 2026
·
8 min read
Press Releases
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 5, 2026
February 5, 2026
·
1 min read
Press Releases
Foundation Medicine Achieves Historic Milestone of 100 Approved and Active Companion Diagnostic Indications, Solidifying Leadership in Precision Medicine
December 5, 2025
·
6 min read
Press Releases
Praxis Precision Medicines to Participate in Upcoming November 2025 Investor Conferences
November 5, 2025
·
2 min read
Press Releases
Praxis Precision Medicines Announces the FDA Has Granted Breakthrough Therapy Designation for Ulixacaltamide HCl in Essential Tremor
December 29, 2025
·
5 min read
1 of 26,699
Next
